ArticleJournal of thoracic disease2026
Mortality and predictive models for 90-/180- day postoperative death for NSCLC patients aged ≥70 years.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Older patients with lung cancer are particularly vulnerable to surgical risks. However, analyses of postoperative mortality and the development of predictive models for patients aged ≥70 years after lung cancer surgery remain limited. Focusing on elderly thoracic surgery patients, this study systematically assessed 90- and 180-day postoperative mortality risks through predictive model development and validation, and ultimately establishing a risk stratification framework to support clinical decision-making and patient management. Methods: Postoperative mortality was analyzed, and prediction models were developed based on elderly patients who received lung cancer surgery at Peking University Cancer Hospital (PKUCH) (from 1995 to 2019). The models were then validated using data from the National Cancer Database (NCDB) cohort from 2004 to 2014. Results: Postoperative mortality rates for patients aged ≥70 years were analyzed in the PKUCH cohort (n=989) and the NCDB cohort (n=16,321). Both cohorts showed increasing mortality from 30 to 180 days after surgery (0.4% and 1.0% within 30 days; 90- and 180-day mortality rates were 1.72%/2.03% and 3.44%/4.19%, respectively. Both models shared four predictors: age, sex, tumor diameter, and surgical approach. The models demonstrated good performance in internal validation [area under the curve (AUC) =0.80 and 0.79] and moderate but clinically useful discrimination in external validation (AUC=0.71 and 0.69). The 90- and 180-day models showed good calibration in both the development cohort (Hosmer-Lemeshow test, P=0.51 and 0.08) and the validation cohorts (P=0.44 and 0.12). Decision curve analysis confirmed the clinical utility of the models. After risk stratification, the high-risk group consistently had the highest mortality rate compared with the medium- and low-risk groups across different ethnic cohorts. Conclusions: Postoperative mortality increased from 0-30 to 91-180 days in patients aged ≥70 years. Prediction models for 90- and 180-day mortality and risk stratification may help guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.